Trial intelligence / Profile preview

Upper Facial Remodeling With Perlane-L and Dysport

NCT01354743Phase 4Completed

Sponsor
Kenneth R. Beer, MD, PA
Start
Dec 2010
Primary completion
Dec 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of botulinum toxin type A in glabellar lines, lateral canthal rhytides, sponsored by Kenneth R. Beer, MD, PA. Started Dec 2010; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

glabellar lineslateral canthal rhytides

Beyond the preview

Go deeper on NCT01354743.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01354743.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call